Zobrazeno 1 - 10
of 786
pro vyhledávání: '"L Thijs"'
Autor:
P. Van Cauwenbergh, V. Samaee, L. Thijs, J. Nejezchlebová, P. Sedlák, A. Iveković, D. Schryvers, B. Van Hooreweder, K. Vanmeensel
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-15 (2021)
Abstract Tailoring heat treatments for Laser Powder Bed Fusion (LPBF) processed materials is critical to ensure superior and repeatable material properties for high-end applications. This tailoring requires in-depth understanding of the LPBF-processe
Externí odkaz:
https://doaj.org/article/f4b1d320a83f4b82853cb50bd58a0cdf
Autor:
Lieneke F.M. Ariëns, Daphne S. Bakker, Lotte S. Spekhorst, Jorien van der Schaft, Judith L. Thijs, Inge Haeck, Annebeth E. Flinterman, Marijke Kamsteeg, Marie L.A. Schuttelaar, Marjolein S. De Bruin-Weller
Publikováno v:
Acta Dermato-Venereologica, Vol 101, Iss 10 (2021)
Dupilumab treatment improves signs, symptoms, and quality of life in patients with moderate-to-severe atopic dermatitis. This study evaluated the impact of dupilumab treatment on absenteeism, presenteeism, and related costs in a large multi-centre co
Externí odkaz:
https://doaj.org/article/8aae7890d16745a0940feeb193d54262
Autor:
Sebastiaan J. Vastert, Femke van Wijk, Timothy R D J Radstake, Barbara Giovannone, Chiara Angiolilli, Marlot van der Wal, Emmerik F A Leijten, Judith L. Thijs, Jorg van Loosdregt, Cornelis P. J. Bekker, Michel Olde Nordkamp, Ella Eeftink
Publikováno v:
Journal of Investigative Dermatology. 142:402-413
Dermal fibroblasts are strategically positioned underneath the basal epidermis layer to support keratinocyte proliferation and extracellular matrix production. In inflammatory conditions, these fibroblasts produce cytokines and chemokines that promot
Autor:
Daphne S. Bakker, Marjolein S. de Bruin-Weller, Judith L. Thijs, Marlies de Graaf, Stefan Nierkens, Edward F. Knol, Eveline M. Delemarre, Julia Drylewicz, Femke van Wijk
Publikováno v:
Journal of Allergy and Clinical Immunology. 149:125-134
Background Increasing evidence shows that pediatric atopic dermatitis (AD) differs from adult AD on a biologic level. Broad biomarker profiling across a wide range of ages of pediatric patients with AD is lacking. Objective Our aim was to identify se
Autor:
Lieneke F.M. Ariëns, Judith L. Thijs, Femke van Wijk, Daphne S. Bakker, Mojtaba Amini, Marjolein S. de Bruin-Weller, Yvonne Vercoulen, Chantal M. van Luijk, José J. M. ter Linde
Publikováno v:
Allergy. 76:3814-3817
Autor:
J Jacobs, W L'hoyes, L Lauwens, C Weltens, J U Voigt, H Wildiers, P Neven, J Herrmann, L Thijs, J Staessen, S Janssens, L Van Aelst
Publikováno v:
European Heart Journal. 43
Background Treatment for breast cancer (BC) frequently involves radiotherapy. Guidelines recommend screening for cardiac adverse events starting 10 years after radiotherapy. The rationale for recommending this interval is unclear and informed the obj
Autor:
Judith L. Thijs, Eveline M. Delemarre, Jorien van der Schaft, Marjolein S. de Bruin-Weller, Edward F. Knol, Stefan Nierkens, Julia Drylewicz, Femke van Wijk, Barbara Giovannone, Daphne S. Bakker
Publikováno v:
Journal of Allergy and Clinical Immunology. 147:189-198
Background Atopic dermatitis (AD) is a highly heterogeneous disease, both clinically and biologically, whereas patients are still being treated according to a “one-size-fits-all” approach. Stratification of patients into biomarker-based endotypes
Autor:
Milad Nazarzadeh, Zeinab Bidel, Dexter Canoy, Emma Copland, Derrick A Bennett, Abbas Dehghan, George Davey Smith, Rury R Holman, Mark Woodward, Ajay Gupta, Amanda I Adler, Malgorzata Wamil, Naveed Sattar, William C Cushman, Richard J McManus, Koon Teo, Barry R Davis, John Chalmers, Carl J Pepine, Kazem Rahimi, L Agodoa, A Algra, F W Asselbergs, N Beckett, E Berge, H Black, F P J Brouwers, M Brown, C J Bulpitt, B Byington, J Cutler, R B Devereaux, J Dwyer, R Estacio, R Fagard, K Fox, T Fukui, Y Imai, M Ishii, S Julius, Y Kanno, S E Kjeldsen, J Kostis, K Kuramoto, J Lanke, E Lewis, J Lewis, M Lievre, L H Lindholm, S Lueders, S MacMahon, G Mancia, M Matsuzaki, M H Mehlum, S Nissen, H Ogawa, T Ogihara, T Ohkubo, C Palmer, A Patel, M Pfeffer, N R Poulter, H Rakugi, G Reboldi, C Reid, G Remuzzi, P Ruggenenti, T Saruta, J Schrader, R Schrier, P Sever, P Sleight, J A Staessen, H Suzuki, L Thijs, K Ueshima, S Umemoto, W H van Gilst, P Verdecchia, K Wachtell, P Whelton, L Wing, Y Yui, S Yusuf, A Zanchetti, Z Y Zhang, C Anderson, C Baigent, BM Brenner, R Collins, D de Zeeuw, J Lubsen, E Malacco, B Neal, V Perkovic, B Pitt, A Rodgers, P Rothwell, G Salimi-Khorshidi, J Sundström, F Turnbull, G Viberti, J Wang
Publikováno v:
Nazarzadeh, M, Bidel, Z, Canoy, D, Copland, E, Bennett, D A, Dehghan, A, Davey Smith, G, Holman, R R, Woodward, M, Gupta, A, Adler, A I, Wamil, M, Sattar, N, Cushman, W C, McManus, R J, Koon, T, Davis, B R, Chalmers, J, Pepine, C J & Rahimi, K 2022, ' Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes : an individual participant-level data meta-analysis ', Lancet Diabetes and Endocrinology, vol. 10, no. 9, pp. 645-654 . https://doi.org/10.1016/S2213-8587(22)00172-3
Background Controversy exists as to whether the threshold for blood pressure-lowering treatment should differ between people with and without type 2 diabetes. We aimed to investigate the effects of blood pressure-lowering treatment on the risk of maj
Autor:
Qi-Fang Huang, Lucas S. Aparicio, Lutgarde Thijs, Fang-Fei Wei, Jesus D. Melgarejo, Yi-Bang Cheng, Chang-Sheng Sheng, Wen-Yi Yang, Natasza Gilis-Malinowska, José Boggia, Teemu J. Niiranen, Wiktoria Wojciechowska, Katarzyna Stolarz-Skrzypek, Jessica Barochiner, Daniel Ackermann, Valérie Tikhonoff, Belen Ponte, Menno Pruijm, Edoardo Casiglia, Krzysztof Narkiewicz, Jan Filipovský, Danuta Czarnecka, Kalina Kawecka-Jaszcz, Antti M. Jula, Murielle Bochud, Thomas Vanassche, Peter Verhamme, Harry A.J. Struijker-Boudier, Ji-Guang Wang, Zhen-Yu Zhang, Yan Li, Jan A. Staessen, LS Aparicio, J Barochiner, L Thijs, JA Staessen, FF Wei, WY Yang, ZY Zhang, YB Cheng, QH Guo, JF Huang, QF Huang, Y Li, CS Sheng, JG Wang, J Filipovský, J Seidlerová, EP Juhanoja, AM Jula, AS Lindroos, TJ Niiranen, SS Sivén, E Casiglia, A Pizzioli, V Tikhonoff, BS Chori, B Danladi, AN Odili, H Oshaju, W Kucharska, K Kunicka, N Gilis-Malinowska, K Narkiewicz, W Sakiewicz, E Swierblewska, K Kawecka-Jaszcz, K Stolarz-Skrzypek, AE Schutte, GR Norton, AJ Woodiwiss, D Ackermann, M Bochud, B Ponte, M Pruijm, R Álvarez-Vaz, C Américo, C Baccino, L Borgarello, L Florio, P Moliterno, A Noboa, O Noboa, A Olascoaga, P Parnizari, M Pécora
Publikováno v:
Hypertension (Dallas, Tex. : 1979)
Huang, Qi-Fang; Aparicio, Lucas S; Thijs, Lutgarde; Wei, Fang-Fei; Melgarejo, Jesus D; Cheng, Yi-Bang; Sheng, Chang-Sheng; Yang, Wen-Yi; Gilis-Malinowska, Natasza; Boggia, José; Niiranen, Teemu J; Wojciechowska, Wiktoria; Stolarz-Skrzypek, Katarzyna; Barochiner, Jessica; Ackermann, Daniel; Tikhonoff, Valérie; Ponte, Belen; Pruijm, Menno; Casiglia, Edoardo; Narkiewicz, Krzysztof; ... (2020). Cardiovascular End Points and Mortality Are Not Closer Associated With Central Than Peripheral Pulsatile Blood Pressure Components. Hypertension, 76(2), pp. 350-358. American Heart Association 10.1161/HYPERTENSIONAHA.120.14787
Hypertension, 76(2), 350-358. LIPPINCOTT WILLIAMS & WILKINS
Hypertension, vol. 76, no. 2, pp. 350-358
Huang, Qi-Fang; Aparicio, Lucas S; Thijs, Lutgarde; Wei, Fang-Fei; Melgarejo, Jesus D; Cheng, Yi-Bang; Sheng, Chang-Sheng; Yang, Wen-Yi; Gilis-Malinowska, Natasza; Boggia, José; Niiranen, Teemu J; Wojciechowska, Wiktoria; Stolarz-Skrzypek, Katarzyna; Barochiner, Jessica; Ackermann, Daniel; Tikhonoff, Valérie; Ponte, Belen; Pruijm, Menno; Casiglia, Edoardo; Narkiewicz, Krzysztof; ... (2020). Cardiovascular End Points and Mortality Are Not Closer Associated With Central Than Peripheral Pulsatile Blood Pressure Components. Hypertension, 76(2), pp. 350-358. American Heart Association 10.1161/HYPERTENSIONAHA.120.14787
Hypertension, 76(2), 350-358. LIPPINCOTT WILLIAMS & WILKINS
Hypertension, vol. 76, no. 2, pp. 350-358
Supplemental Digital Content is available in the text.
Pulsatile blood pressure (BP) confers cardiovascular risk. Whether associations of cardiovascular end points are tighter for central systolic BP (cSBP) than peripheral systolic BP (pSBP) or
Pulsatile blood pressure (BP) confers cardiovascular risk. Whether associations of cardiovascular end points are tighter for central systolic BP (cSBP) than peripheral systolic BP (pSBP) or
Autor:
Ilona de Ridder, Geertruida L E Romeijn, Lotte S. Spekhorst, Marijke Kamsteeg, Lieneke F.M. Ariëns, Marie L A Schuttelaar, Marlies de Graaf, Jorien van der Schaft, A. J. Oosting, Annemiek Sloeserwij, Marjolein S. de Bruin-Weller, Daphne S. Bakker, Inge Haeck, Judith L. Thijs
Publikováno v:
Allergy
Allergy, 75, 2376-2379
Allergy, 75, 9, pp. 2376-2379
Allergy, 75(9), 2376-2379. Wiley-Blackwell
Allergy, 75, 2376-2379
Allergy, 75, 9, pp. 2376-2379
Allergy, 75(9), 2376-2379. Wiley-Blackwell
Contains fulltext : 225155.pdf (Publisher’s version ) (Open Access)